biotech

China’s growing pipeline of novel drug candidates is expected to draw increased attention from global pharmaceutical companies and investors scouting…

Many wealthy families in Asia, the Middle East and Europe are exploring Hong Kong as a platform to tap growing…

Washington should focus its industrial policy on strategic, cutting-edge technologies rather than trying to bring back manufacturing wholesale, particularly in…

Two Chinese drug developers have signed licensing deals that could yield as much as US$2.5 billion in performance-based payments, underscoring…

Hong Kong Exchanges and Clearing (HKEX) plans to launch the Hang Seng Biotech Index Futures next month, as offshore investors…

Beijing’s new rules for state-led bulk tendering of medical drugs are the latest example of its “anti-involution” drive to combat…

US investors are showing the highest level of interest in Chinese stocks in five years, and their return to China’s…

China’s healthcare sector is on track to secure record fundraising this year, driven by robust global investor demand and growth…

Chinese Premier Li Qiang has called for stronger policy support for the biotech industry, as part of efforts to bolster…

China’s cost and efficiency advantages in drug development have been recognised at the world’s largest cancer research conference in the…